Huizenga Theodore Alan Insider Trades

Insider Trading History

Track insider trading activity for Huizenga Theodore Alan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.61M 68,911 shares
Last Trade
Apr 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$679k 27,589 shares
$24.61
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.13M 48,670 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.2k 1,632 shares
$22.80
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.17M 50,302 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.46k 148 shares
$23.39
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.18M 50,450 shares
Last Trade
Dec 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.68k 85 shares
$19.72
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.17M 50,242 shares
Last Trade
Sep 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.87k 64 shares
$29.17
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.17M 50,306 shares
Last Trade
Sep 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.64k 84 shares
$31.39
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.17M 50,265 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.7k 967 shares
$42.10
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.17M 50,124 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.05k 141 shares
$42.92
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $1.19M 51,232 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 5,632 shares
$42.92
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $975k 41,840 shares
Last Trade
Dec 10, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$31.8k 648 shares
$49.09
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $985k 42,251 shares
Last Trade
Sep 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.6k 700 shares
$59.36
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $969k 41,551 shares
Last Trade
Sep 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.11k 91 shares
$56.19
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $964k 41,366 shares
Last Trade
Apr 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$592 14 shares
$42.31
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $975k 41,842 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 10,551 shares
$56.74
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $965k 41,380 shares
Last Trade
Mar 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.3k 341 shares
$53.76
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $973k 41,721 shares
Last Trade
Mar 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.5k 121 shares
$53.69
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $650k 27,892 shares
Last Trade
Jan 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$145k 3,000 shares
$48.17
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Jan 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$145k 3,000 shares
$48.17
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $574k 24,614 shares
Last Trade
Dec 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.4k 1,000 shares
$45.39
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Svp, Chief Accounting Officer
Holding Value $54.8k 2,351 shares
Last Trade
Sep 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.8k 2,351 shares
$36.91
$23.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up